Thomas Sciascia
Chief Scientific Officer · Trevi Therapeutics, Inc.
Individual
- 2025
- Feb 20, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas Sciascia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Thomas Heffernan - $596K in TRVI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas Sciascia?
Thomas Sciascia is a corporate insider, tracked as Chief Scientific Officer of Trevi Therapeutics, Inc. (TRVI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Thomas Sciascia last file a Form 4?
The most recent primary Form 4 on record is dated 20 February 2026, one of 2 filings going back to 2025.